Bridge the Gap’s International SYNGAP1 Conference provides a cutting-edge, scientific and educational
forum focused on bringing together a diverse group of SYNAP1 Community stakeholders. SYNGAP1 Community stakeholders include - research scientists, clinical specialists, SYNGAP1 Families, industry, academic, governmentand community leaders.
In addition, the conferences provide opportunities to bring together scientists and clinicians actively involved in SYNGAP1 Research with trainees,young investigators, and underrepresented minorities, as well as, experts in the development of targeted therapies related to neurodevelopmental disorders. Our goal is to increase participation of trainees,young investigators and underrepresented minorities in neurodevelopmental disorder research and to encourage the development of targeted therapies to treat SYNGAP1 and related neurodevelopmental disorders.
The conferences are designed to maximize scientific resources, encourage opportunities for collaboration and provide a forum that is inclusive for SYNGAP1 families and caregivers. Each conference features a broad range of sessiontopics related to SYNGAP1 mutations, related neurodevelopmental disorders, published and unpublished research data and patient-centric study design. Time is allotted during each presentation for SYNGAP1 experts to lead discussions on current and future avenues of research.
Interested in attending aLearn More Here
BTG - International SYNGAP1 Scientific Conference?